A
Asceneuron
0 followers
Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.
Org chart
Barbara Angehrn Pavik
Chief Executive Officer
Barbara Angehrn Pavik
Collapse
Sandra Millet
Head Of Operations
Matthew Foy
Investor
Eric Yuen
Scientific Advisory Board Member
Andrin Cerletti
Head Of Business Development
Abbas Hussain
Chairman
Henrijette Richter
Board Member
Ruhi Ahmed
SVP & Head of Regulatory Affairs
Bruno Permanne
Senior Director & Head of Preclinical Development
Colin Kahrs
Head of Intellectual Property
Board & advisors
Peter Van Vlasselaer
Chairperson
Henrijette Richter
Director
Hakan Goker
Director
Deborah Harland
Director
Lior Teitelbaum
Director
Eric Yuen
Director
Catherine Moukheibir
Director
Raymond G. Hill
Scientific Advisor
Christian Haass
Scientific Advisor
Adam Boxer
Scientific Advisor
Günter U. Höglinger
Scientific Advisor